Category: PCI -DES Background: Reports presented at European Society of Cardiology (ESC) 2006 meeting about increased mortality associated with drug-eluting stents (DES), possibly due to late stent thrombosis, sparked controversy and prompted the U.S. Food and Drug Administration to recommend using DES according to label indications only. In early 2007, pooled analyses with longer follow up disproved the controversial findings. We studied how these developments affected stent use at our institution. . All percutaneous coronary intervention (PCI) cases with stent placement were analyzed.
